Use of Handheld Fans in Management of Hot Flashes in Women With Breast Cancer Receiving Hormonetherapy

NCT07054957 | Completed DMC

• 1 other identifier: Bakırçay Üniversitesi
• Study Type: interventional
• Target: 64
• Locations: 1 country
• Sites: 1

Brief Summary

Hot flushes are a common symptom in women with breast cancer receiving hormone therapy. It can lead to conditions that reduce quality of life such as sleep quality deterioration, sexual problems and discomfort in daily life. Effective management of the symptom improves the quality of life of patients. The aim of the study was to examine the effect of handheld fan use in the management of hot flashes in women with breast cancer receiving hormone therapy. Hypotheses of the research: H1: Handheld fan use has no effect in managing hot flashes in women with breast cancer receiving hormone therapy. H2: The use of handheld fan has an effect on the management of hot flashes in women with breast cancer receiving hormone therapy. This randomised controlled study was a pretest-posttest experimental design. The study sample consisted of 64 breast cancer patients (n = 32 for each of the intervention and control groups) receiving hormone therapy treatment in the medical oncology department of a university hospital. The intervention group used a hand-held fan when experiencing hot flush symptoms, while the control group did not receive any intervention. The pre-test and post-test Visual Analogue Scale (VAS) and hot flush belief scale scores and the results of the individual identifying information form were compared for both groups.

Conditions

Breast Cancer; Handheld Fan; Hot Flashes; Hormonetherapy

Keywords

breast cancer; hormonetherapy; handheld fan; hot flashes; symptom management

Outcome Measures

Primary Outcomes (3)

• Individual Information Form

  This form contains questions about sociodemographic characteristics, diseases and symptoms.

  12 weeks

• Visual Analog Scale (VAS)

  Visual Analog Scale (VAS); VAS is used to quantify some values that cannot be measured numerically. It consists of a 10 cm long line at one end, which is expressed as very good for the individual/patient and very bad at the other end. VAS is also a valid and reliable measurement tool for measuring other subjective emotions such as mood. In this study, VAS is preferred for the hot flashes experienced by women with breast cancer receiving hormone therapy

  12 weeks

• Hot Flashes Belief Scale

  The scale consists of 27 items and three sub-dimensions. The beliefs about oneself in a social context sub-dimension: It was formed with 13 items (1, 6-11, 13, 14, 17, 20, 21, 23) that describe how women feel when they experience hot flashes in social environments. The beliefs about coping with hot flashes sub-dimension: It was formed with 10 items (2, 5, 12, 15, 16, 18, 19, 24, 26, 27) that describe beliefs about coping with hot flashes. Beliefs about coping with night sweats sub-dimension: It consists of 4 items (3, 4, 22, 25) describing women's beliefs about coping with night sweats. Each item of the scale is rated on a 6-point Likert type scale ranging from "strongly disagree" (0 points) to "strongly agree" (5 points). It is stated that items 2, 4, 5, 11, 15, 18, 25 of the scale are reverse coded. The total score of the scale varies between 0-135, and a high score on the scale indicates a high level of negative belief.

  12 weeks

Study Arms (2)

Control group

NO INTERVENTION

pre-test, mid-test and final test will be administered.

İntervention group

EXPERIMENTAL

Group using hand fans

Other: Handheld fan; Other: Control Group

Interventions

Handheld fan OTHER

Group using hand fans

İntervention group

Control Group OTHER

pre-test, mid-test and post-test will be administered.

İntervention group

Eligibility Criteria

• Age: 18 Years+
• Gender Eligibility Details: MANAGEMENT OF HOT FLASHES IN WOMEN WITH BREAST CANCER RECEIVING HORMONETHERAPY
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Diagnosis of clinical breast cancer
• Experiencing hot flashes

You may not qualify if:

• \- Menopausal women

Sponsors & Collaborators

• Izmir Bakircay University: lead

Study Sites (1)

Izmir Bakircay University

Izmir, Seyrek/Menemen, 35100, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Breast Neoplasms; Hot Flashes

Interventions

Control Groups

Condition Hierarchy (Ancestors)

Neoplasms by Site; Neoplasms; Breast Diseases; Skin Diseases; Skin and Connective Tissue Diseases; Signs and Symptoms; Pathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Epidemiologic Research Design; Epidemiologic Methods; Investigative Techniques; Research Design; Methods

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: SINGLE
• Who Masked: PARTICIPANT
• Purpose: OTHER
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principal Investigator

Model Details: This study was conducted in a single-blind, single-center, randomized controlled design in breast cancer patients receiving hormone therapy in an outpatient chemotherapy unit. This study was conducted in the outpatient chemotherapy unit of a training and research university hospital in Turkey between November 2023 and October 2024.: This randomised controlled study was a pretest-posttest experimental design. The study sample consisted of 64 breast cancer patients (n = 32 for each of the intervention and control groups) receiving hormone therapy treatment in the medical oncology department of a university hospital. The intervention group used a hand-held fan when experiencing hot flush symptoms, while the control group did not receive any intervention.

Study Record Dates

• First Submitted: June 3, 2025
• First Posted: July 8, 2025
• Study Start: November 15, 2023
• Primary Completion: January 15, 2024
• Study Completion: October 15, 2024
• Last Updated: July 8, 2025

Record last verified: 2025-07

Data Sharing

• IPD Sharing: Will not share

Locations

TU (1)